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Abstract P-selectin purified from human platelets, when
immobilized on a solid surface, induced monocytes to release
tumor necrosis factor-K (TNF-K). The induction of TNF-K
release was dependent on the concentration of P-selectin used for
the immobilization, and the maximal stimulation was observed
when the plate was coated with 0.3 Wg/ml of P-selectin. Use of
either a higher or a lower concentration of P-selectin for the
plate-coating was found to elicit less TNF-K release, although the
higher concentration of P-selectin caused a stronger adhesion of
HL-60 leukemic cells. The expression of mRNA for TNF-K
roughly paralleled the TNF-K secretion, as assessed by RT-PCR.
These results indicate that monocytes are activated by immobi-
lized P-selectin in a density-dependent manner. ß 2000 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
P-selectin is a carbohydrate-binding cell adhesion molecule
expressed on activated endothelial cells and platelets. A num-
ber of studies have provided evidence that members of the
selectin family (E-, L- and P-selectin) control leukocyte traf-
¢cking [1^4]. P-selectin-mediated leukocyte adhesion to vascu-
lar endothelial cells and activated platelets has been shown to
play a crucial role in the initial step of the recruitment of
leukocytes into in£ammatory and hemorrhagic sites. It has
been proposed that P-selectin binds to carbohydrate chains
containing sialyl Lewis X (sLeX) structure [Sialic acid K2-
3Gal L1-4 (Fuc K1-3) GlcNAc L1-R] (CD15S), which is dis-
tributed on the surface of leukocytes, especially neutrophils
and monocytes [5,6]. A functional ligand for P-selectin was
identi¢ed and designated as PSGL-1 (P-selectin glycoprotein
ligand-1) [7].
We previously showed that P-selectin-dependent adhesion
of activated platelets to neutrophils and monocytes led to
the activation of these leukocytes to generate the extracellular
superoxide anion [8,9]. This result suggested that P-selectin
sent an activation signal into the leukocytes through its coun-
ter-receptor. We have also shown that sLeX at the termini of
O-linked carbohydrate chains of membrane glycoproteins are
essential in signal transduction leading to superoxide anion
production [10]. In addition, studies have shown that P-selec-
tin is able to stimulate other leukocyte functions, such as
expression of tissue factor in monocytes [11] and phagocytotic
activity of neutrophils and monocytes [12,13]. It has also been
demonstrated that co-stimulation with P-selectin and platelet-
activating factor induces monocytes to secrete monocyte che-
motactic protein-1 and tumor necrosis factor-K (TNF-K) [14].
It is likely that the P-selectin-induced production of oxygen
radicals, cytokines and coagulation factors will be implicated
in the initiation and progression of the in£ammation and
blood coagulation processes. We recently found that immobi-
lized P-selectin but not soluble P-selectin was able to induce
leukocyte activation for the superoxide anion production, and
that the redistribution of the counter-receptors for P-selectin
containing sLeX carbohydrate chains was an essential process
for the activation [15]. Thus, the signaling for the leukocyte
activation induced by P-selectin seems to be somewhat di¡er-
ent from that induced by other soluble stimulants. In this
study, we investigated the ability of P-selectin to induce
TNF-K production in monocytes, and found that immobilized
P-selectin was able to induce extracellular release of TNF-K in
a density-dependent manner.
2. Materials and methods
2.1. Reagents
Ficoll^Paque, ConA^Sepharose 4B and heparin^Sepharose 4B were
products of Pharmacia (Uppsala, Sweden). Dextran 200 (special grade
for leukocyte isolation; molecular weight: 180 000^210 000) was pur-
chased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
2P,7P-Bis(carboxyethyl)carboxy£uorescein tetraacetoxymethyl ester
(BCECF-AM) was a product of Dojindo Laboratories (Kumamoto,
Japan). RPMI 1640 medium was a product of Gibco/BRL (Gaithers-
burg, MD, USA).
2.2. Antibodies
Monoclonal antibody (mAb) against human P-selectin (2T60,
IgG1) [16] was a gift from Dr. K. Tanoue (the Tokyo Metropolitan
Institute of Medical Science). Another mouse monoclonal anti-P-se-
lectin antibody (2D7, IgG1) was established in our laboratory. For
the puri¢cation of human P-selectin, mAb 2D7 was conjugated to
CNBr-activated Sepharose 4B (Pharmacia) according to the manufac-
turer’s instructions.
2.3. Cells
Monocytes were puri¢ed from normal human peripheral blood by a
combination of dextran sedimentation and Ficoll^Paque gradient cen-
trifugation [8,17]. Heparinized whole blood was mixed with an equal
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volume of 3% dextran/0.15 M NaCl and allowed to stand for 30 min.
After most of the erythrocytes had settled as sediment at the bottom
of the tube, the supernatant was centrifuged at 250Ug for 10 min.
The pelleted cells were then suspended in 10 mM sodium phosphate
bu¡er (pH 7.3) containing 0.14 M NaCl (phosphate-bu¡ered saline
(PBS)) and layered on Ficoll^Paque solution. After centrifugation at
400Ug for 20 min, cells at the interface were collected, suspended in
PBS, and centrifuged at 250Ug for 10 min. Cells were suspended at a
density of 1U106 cells/ml in RPMI 1640 medium containing 10%
FBS, and the cell suspension was incubated at 37‡C for 30 min in a
plastic culture dish. After non-adherent cells were removed by wash-
ing the dish twice with warm PBS, adherent cells were recovered with
a cell scraper in PBS containing 0.02% EDTA. The cells were washed
with RPMI 1640 medium containing 10% FBS. All procedures were
performed under sterile conditions. The purity of the monocytes prep-
arations was more than 90%, as evaluated by May^Gruenwald^Giem-
sa staining. The trypan blue exclusion assay showed that 99% of the
cells were viable.
HL-60, a human myelocytic leukemia cell line, and L.P3, a subline
of mouse L cells, were supplied by the RIKEN Cell Bank (Wako,
Japan) and Health Science Research Resources Bank (Osaka, Japan),
respectively. These cells were cultured in RPMI 1640 medium contain-
ing 10% FBS under a 5% CO2 atmosphere.
2.4. Puri¢cation of P-selectin from human platelets
P-selectin was puri¢ed from human platelets as described by John-
ston et al. [18] with the following modi¢cation. Human platelets (4.0
ml of packed cells) were lysed by sonication in 40 ml of PBS contain-
ing protease inhibitors (1 mM phenylmethanesulfonyl £uoride
(PMSF), 0.2 mM leupeptin, 1 WM pepstatin, 1 mM N-ethyl male-
imide, 0.1 mM aprotinin, 3.5 mM EDTA), and centrifuged at
100 000Ug for 30 min at 4‡C. The pellet was then suspended in 40
ml of PBS containing 1% NP-40 and the protease inhibitor cocktail
described above, incubated at 0‡C for 1 h, and centrifuged at
100 000Ug for 30 min at 4‡C. The supernatant thus obtained was
applied to a column of ConA^Sepharose 4B (Pharmacia). After the
column was washed with PBS containing 0.1% NP-40, bound glyco-
proteins were eluted with PBS containing 0.1% NP-40 and 0.5 M
methyl-K-D-mannoside, and dialyzed against 10 mM sodium phos-
phate bu¡er (pH 7.3) containing 0.1 M NaCl and 0.1% NP-40
(0.1 M NaCl/0.1% NP-40/PB). The crude glycoprotein fraction was
then applied to a column of heparin^Sepharose 4B (Pharmacia) which
had been equilibrated with 0.1 M NaCl/0.1% NP-40/PB. The elution
was sequentially conducted with 0.1 M NaCl/0.1% NP-40/PB, 0.25 M
NaCl/0.1% NP-40/PB and 0.5 M NaCl/0.1% NP-40/PB. The eluate
with 0.25 M NaCl/0.1% NP-40/PB from the heparin^Sepharose 4B
column was then subjected to a⁄nity chromatography on a column
of anti-P-selectin antibody (2D7) conjugated to Sepharose 4B. After
the column was washed with 0.1% NP-40/PBS and then with 1.5 M
KSCN/0.1% NP-40, P-selectin bound to the column was eluted with
3 M KSCN/0.1% NP-40 and immediately dialyzed against PBS.
2.5. Monocyte culture and measurement of TNF-K
A 96 well culture plate was coated with puri¢ed P-selectin (0.04^20
Wg/ml) in 0.2 M NaHCO3 at 4‡C for 16 h. After the well was washed
with PBS three times and then blocked with 3% bovine serum albumin
(BSA)/PBS, monocytes (5U105 cells/ml, 0.2 ml) were placed in a well
and cultured at 37‡C for 0.5^6 h. TNF-K secreted into the culture
supernatant was measured by the cytotoxic test using the mouse ¢-
broblastic cell line L.P3 as described previously [19]. One unit/ml of
TNF-K was de¢ned as the concentration which gave 50% cytotoxicity
against L.P3 cells. The cytotoxic activity of the monocyte culture
supernatant was almost completely blocked by the addition of an
anti-TNF-K antibody (a gift from Dr. Masahiro Higuchi, Institute
of Molecular Medicine for the Prevention of Human Diseases, Hous-
ton, TX, USA), indicating that the cytotoxicity was mainly caused by
TNF-K. In some experiments, the level of TNF-K was also determined
by ELISA (R and D systems, Minneapolis, MN, USA). 1 Wg of TNF-
K corresponded to 5U104 units in the cytotoxic assay.
2.6. Cell adhesion assay
The adhesion of HL-60 cells to P-selectin was assayed essentially as
described previously [20]. Brie£y, HL-60 cells were labeled with a
£uorescent dye, BCECF-AM (3 WM), at 37‡C for 30 min. The labeled
cell suspension (1U106 cells/ml, 0.1 ml) in RPMI 1640/1% BSA was
placed in a 96 well culture plate that had been coated with P-selectin
under the same conditions as used for the TNF-K assay. After the
plate was incubated at 0‡C for 1 h, non-adherent cells were removed,
the well was gently washed three times with RPMI 1640/1% BSA, and
adherent cells were lysed with 0.2 ml of 1% SDS. The £uorescence
intensity was measured with a £uorescence spectrophotometer
(ex = 490 nm, em = 520 nm).
2.7. Reverse transcription-polymerase chain reaction (RT-PCR)
analysis of TNF-K mRNA
Total cellular RNA was isolated from monocytes incubated with P-
selectin using an Ultraspec1 kit (Biotecx Laboratories Inc., Houston,
TX, USA) according to the manufacturer’s instructions. Reverse tran-
scription of 2 Wg of total RNA was conducted with M-MLV reverse
transcriptase (4 units/Wl) (Gibco/BRL) and an oligo dT12ÿ18 primer
(50 ng/ml) (Pharmacia). An aliquot of the cDNA was then subjected
to PCR using a sense primer, 5P-ATGAGCACTGAAAGCATGATC-
3P, and an antisense primer, 5P-TCACAGGGCAATGATCCCAA-
AGTAGACCTGCCC-3P [21]. The PCR protocol consisted of 30
cycles of 1.5 min at 94‡C, 2 min at 45‡C, and 3 min at 72‡C. The
PCR products were analyzed by gel electrophoresis in 1.5% agarose
followed by staining with ethidium bromide.
3. Results
3.1. Puri¢cation of P-selectin from human platelets
When puri¢ed P-selectin was analyzed by SDS-polyacryl-
amide gel electrophoresis under a reducing condition and
stained by the silver staining method, a single band with Mr
of approx. 140 kDa was observed (Fig. 1). Electrophoresis
under a non-reducing condition gave a band with slightly
higher mobility (data not shown), which was consistent with
the previous report [18].
The level of bacterial endotoxin contamination in the P-
selectin preparation was lower than 0.7 pg/Wg P-selectin, as
determined by the Limulus test using an Endotoxin Test kit
(Seikagaku Kogyo Co., Ltd., Tokyo, Japan).
3.2. Induction of TNF-K secretion by immobilized P-selectin
We ¢rst examined whether P-selectin-mediated adhesion in-
duced the release of TNF-K from human monocytes. The level
of TNF-K in the culture medium of monocytes incubated for
6 h in a P-selectin-coated plate was increased about 20-fold
relative to that in the medium incubated in a BSA-coated
Fig. 1. Electrophoretic analysis of P-selectin puri¢ed human plate-
lets. P-selectin puri¢ed by the procedure described in Section 2 was
subjected to SDS-polyacrylamide gel electrophoresis under a reduc-
ing condition. The gel was stained by the silver-staining method.
Molecular weights of marker proteins are given in kDa.
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plate (Fig. 2A). The increased TNF-K secretion was inhibited
by the addition of a monoclonal antibody against human P-
selectin (2T60) (Fig. 2B), indicating that the induction of
TNF-K secretion was P-selectin-dependent. We next deter-
mined the time kinetics for TNF-K secretion from monocytes
following their adhesion to P-selectin-coated plates. There was
a signi¢cant increase in TNF-K activity in the culture super-
natant 4 h following the adhesion (Fig. 3). The kinetics for P-
selectin-induced TNF-K release was similar to that obtained
for bacterial lipopolysaccharide (LPS).
Plates were coated with various concentrations of P-selec-
tin, and each concentration was tested for its ability to acti-
vate monocytes. As shown in Fig. 4, the maximal TNF-K
secretion was observed when monocytes were cultured in a
plate coated with 0.3 Wg/ml of P-selectin. The level of TNF-
K in the supernatant of this culture (680 units/5U105 cells)
was comparable to that induced by LPS. When either higher
or lower concentrations of P-selectin were used to coat the
plates, TNF-K release was less e¡ectively induced. By con-
trast, measurement of the adhesion of HL-60 cells to plates
coated with the same concentrations of P-selectin under the
same condition resulted in a pro¢le distinct from that for
TNF-K secretion. The percentage of adhered cells increased
with increasing concentration of P-selectin, and reached a
maximal level at 5 Wg/ml. This result indicated that the P-
selectin-induced TNF-K secretion and adhesion were not nec-
essarily correlated, but that there was a clear optimal density
of immobilized P-selectin for the former e¡ect.
3.3. Detection of mRNA for TNF-K by RT-PCR
Next, we attempted to detect mRNA for TNF-K in mono-
cytes cultured in plates coated with various concentrations
(0.1^10 Wg/ml) of P-selectin by the RT-PCR method. The
expected PCR product (702 bp) for human TNF-K was ob-
tained from cells cultured with immobilized P-selectin (Fig. 5).
Its identity was con¢rmed by restriction endonuclease diges-
Fig. 2. Induction of TNF-K release from human monocytes by im-
mobilized P-selectin. A: Human monocytes (5U105 cells/ml, 0.2 ml)
were cultured at 37‡C for 6 h in a 96 well plate which had been
coated with P-selectin (10 Wg/ml). TNF-K released in the superna-
tant was measured by the cytotoxic assay as described in Section 2.
In a control experiment, monocytes were incubated in wells treated
with the bu¡er (3 M KSCN/0.1% NP-40) that was used for the ¢nal
step of the puri¢cation of P-selectin. Monocytes were also incubated
with LPS (0.1 Wg/ml) as a positive control. B: The e¡ect of F(abP)2
fragment of anti-P-selectin (2T60) was examined. The plate was
coated with P-selectin (0.5 Wg/ml). Triplicate assays were performed
in each experiment; S.D. is indicated by an error bar.
Fig. 3. Time course of TNF-K release induced by immobilized P-se-
lectin. Human monocytes (5U105 cells/ml, 0.2 ml) were cultured at
37‡C for 0.5^6 h in a 96 well plate which had been coated with P-
selectin (10 Wg/ml). TNF-K released in the supernatant was mea-
sured by the cytotoxic assay as described in Section 2. Control ex-
periments were also conducted in the absence or presence of LPS
(0.1 Wg/ml) using uncoated plates.
Fig. 4. P-selectin-induced TNF-K release from human monocytes
and adhesion of HL-60 cells. For the TNF-K release assay, human
monocytes (5U105 cells/ml, 0.2 ml) were cultured at 37‡C for 6 h in
a 96 well plate that had been coated with various concentrations
(0.04^20 Wg/ml) of P-selectin. TNF-K released in the supernatant
was measured by the cytotoxic assay as described in Section 2 (b).
TNF-K released from LPS (0.1 Wg/ml)-treated monocytes was also
measured (8). For the adhesion assay, BCECF-AM-labeled HL-60
cells (1U106 cells/ml, 0.1 ml) were incubated at 4‡C for 1 h in a 96
well plate that had been coated with P-selectin under the same con-
ditions as for the TNF-K assay. After the non-adherent cells were
washed, the £uorescence intensity of the adhered cells was deter-
mined (E).
Fig. 5. Analysis of mRNA for TNF-K by the RT-PCR method.
After human monocytes (106 cells/ml, 2.0 ml) were cultured at 37‡C
for 2 h in a 6 well plate that had been coated with various concen-
trations (0.1^10 Wg/ml) of P-selectin, RNA was isolated and sub-
jected to RT-PCR under the conditions described in Section 2. RT-
PCR using primers for L-actin as an internal control was also con-
ducted [22].
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tion with Ava I, which yielded 452 and 250 bp fragments [21].
The relative intensities of the bands for each of the PCR
products roughly paralleled the results of the TNF-K assay
shown in Fig. 4. Again, this indicated that the density of P-
selectin immobilized on the plate was critical for the monocyte
activation. Since the control experiments showed that the lev-
els of L-actin mRNA were similar between monocytes cul-
tured with and those cultured without P-selectin, the e⁄ciency
of the RT-PCR was comparable among the experimental
groups. The results also suggested that the induction of
TNF-K secretion was transcriptionally regulated.
4. Discussion
It has been well demonstrated that P-selectin on activated
endothelium and platelets plays a crucial role in leukocyte
tra⁄cking through its interaction with the counter-receptors
containing carbohydrate chains on the leukocyte surface. In
addition to its function in mediating intercellular adhesion, P-
selectin has also been demonstrated to serve as a signal trans-
mitting molecule. Several researchers, including the present
authors, have shown that leukocyte functions such as tissue
factor expression on monocytes [11], phagocytotic activity of
neutrophils and monocytes [12,13], in£ammatory cytokine se-
cretion [14] and superoxide anion production in neutrophils
[15] are potentiated by P-selectin alone or in combination with
other agonists. On the other hand, Wong and co-workers
reported that P-selectin had a suppressive e¡ect on the pro-
duction of oxygen radicals in neutrophils [23]. Thus, the func-
tion of P-selectin in cellular signaling remains controversial.
In the present study, we demonstrated that P-selectin puri-
¢ed from human platelets was capable of activating mono-
cytes to release TNF-K (Fig. 2). Furthermore, the induction
of TNF-K release was dependent on the density of P-selectin
immobilized on the culture plates, and an optimal density of
P-selectin for the e⁄cient production of the cytokine was de-
termined (Fig. 4). In the RT-PCR analysis, mRNA for TNF-
K was found to be upregulated and the quantities of the am-
pli¢ed products were roughly correlated with the TNF-K re-
lease (Fig. 5). These results indicated that the high density of
P-selectin was not necessarily required for the monocyte acti-
vation, although such density did support the ¢rm cell adhe-
sion. This observation might partly explain the disagreement
in the reported e¡ects of P-selectin on leukocyte activation.
Although the reason for the insu⁄cient activation of mono-
cytes by higher density of P-selectin remains uncertain, we
assume that the biphasic e¡ect of immobilized P-selectin on
TNF-K production was due to the di¡erence in the extent of
the cross-linking of the counter-receptor for P-selectin on the
cell surface. We recently reported that the redistribution of the
counter-receptor containing sLeX carbohydrate chains was
essential for the leukocyte activation leading to superoxide
anion production through P-selectin [15]. It is likely that mod-
erate cross-linking of the counter-receptors is crucial for trans-
mission of a signal into cells. However, the correlation be-
tween the distribution of sLeX epitopes on the cell
membranes and TNF-K production, when various concentra-
tions of P-selectin were used for the plate coating, has not
been clearly demonstrated, and further studies will be needed
on this subject.
It cannot be ruled out that the secretion of TNF-K may be
negatively regulated by a feedback mechanism mediated by
other cytokines [24] or cellular regulatory proteins [25]. Con-
sidering that no such phenomenon was observed when mono-
cytes were stimulated by LPS and that TNF-K secretion oc-
curred over relatively short periods, it is likely that the
density-dependent and biphasic induction of TNF-K release
by P-selectin involves a speci¢c mechanism. Another possibil-
ity is that certain inhibitory factors contaminated the P-selec-
tin preparation and reduced the e⁄ciency of the TNF-K pro-
duction. This seems unlikely, however, since a partial
absorption experiment in which a high concentration (10 Wg/
ml) of P-selectin was adsorbed with a small amount of the
anti-P-selectin antibody^protein G-agarose conjugate prior to
the plate coating resulted in potentiation of TNF-K produc-
tion (data not shown).
TNF-K is known to play a key role in orchestrating in£am-
mation, immunity and thrombosis [26^28]. P-selectin has also
been shown to play a major role in thrombogenic and in£am-
matory processes in the vascular system via its function in
leukocyte recruitment. The expression of various cell adhesion
molecules including E-selectin, another member of the family
of endothelial selectins, is also induced by TNF-K. The com-
bination of the stimulation by in£ammatory cytokines and by
adhesion molecules may exacerbate the pathogenesis of vari-
ous in£ammatory disorders. Wake¢eld and coworkers re-
cently reported that the combined administration of anti-
TNF-K and anti-P-selectin antibodies e¡ectively attenuated
the in£ammation induced by venous thrombosis in rats [29].
The interaction of P-selectin and leukocytes may thus be one
of the key steps in the etiology of various in£ammatory dis-
eases.
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